Clinical Trials
3 trialsNCT04678102 2023-06-26
CREATIVE
Seoul National University Hospital
Phase 1 Unknown
NCT05736952 2023-05-11
Oral Topotecan Combined With Anlotinib in Patients With Platinum-resistant Recurrent Ovarian Cancer
Xinhua Hospital, Shanghai Jiao Tong University School of Medicine
Phase 2 Withdrawn
NCT04376073 2020-11-25
ANNIE
Sun Yat-sen University
Phase 2 Unknown